40 Participants Needed

Mindful Self-Compassion for Anxiety and Depression

AS
CS
Overseen ByCharisma, Study Coordinator
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial allows some psychiatric medications, like certain sleep medications and anti-depressants, if you've been on a stable dose for at least 8 weeks before starting and plan to continue at the same dose during the trial. However, medications like barbiturates or antipsychotics are not allowed.

What data supports the effectiveness of the treatment Mindful Self-Compassion for Anxiety and Depression?

Research shows that mindfulness and self-compassion training can reduce symptoms of depression and anxiety. Studies found that these practices help increase self-compassion and mindfulness, which are linked to better mental health outcomes.12345

Is Mindful Self-Compassion safe for humans?

Research on Mindful Self-Compassion and related practices like Mindfulness Meditation and Compassion Focused Therapy suggests they are generally safe for humans, with studies showing benefits like reduced anxiety and depression without reporting significant adverse effects.24567

How does the Mindful Self-Compassion treatment differ from other treatments for anxiety and depression?

Mindful Self-Compassion (MSC) is unique because it combines mindfulness meditation with self-compassion training, focusing on self-kindness, common humanity, and mindfulness to help individuals relate to painful experiences. Unlike other treatments, MSC is an 8-week program that includes meditations and informal practices like soothing touch and self-compassionate letter writing, aiming to cultivate self-compassion and improve emotional regulation.13458

What is the purpose of this trial?

The study will compare 8-week Mindful Self-Compassion training, compared to a control group that does not receive the intervention, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder.

Research Team

EH

Elizabeth Hoge, MD

Principal Investigator

Georgetown University

Eligibility Criteria

This trial is for adults with anxiety disorders (like social anxiety, generalized anxiety, panic disorder, or agoraphobia) or major depression who feel they aren't very self-compassionate. Participants must understand the study and agree to all parts of it. People can't join if they've had certain mental health treatments recently, have severe medical conditions that could interfere, are pregnant, prisoners, or plan to be away during the study.

Inclusion Criteria

I can understand and agree to the study's procedures.
Must score low on self-compassion, as measured by the self-compassion scale
Must understand study procedure and willing to participate in all testing visits, and treatment as assigned
See 1 more

Exclusion Criteria

Pregnant women
I have had serious thoughts or actions of suicide in the last year.
Prisoners
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Mindful Self-Compassion training in weekly classes for 8 weeks

8 weeks
8 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Mindful Self-Compassion
Trial Overview The trial tests an 8-week Mindful Self-Compassion program against a control group not receiving this training. It aims to see if this approach helps reduce symptoms of anxiety and depression in participants compared to those who don’t receive the intervention.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Self-CompassionExperimental Treatment1 Intervention
Mindful Self-Compassion (MSC) is a weekly class given for 8 weeks. The individual classes last about 2 hours each. The class is provided in a group setting.
Group II: Treatment as Usual (TAU)Active Control1 Intervention
The TAU arm will not receive the additional treatment from the study. Subjects will receive psychiatric treatment from their usual providers.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Georgetown University

Lead Sponsor

Trials
355
Recruited
142,000+

Findings from Research

Mindfulness-Based Compassionate Living (MBCL) was found to be feasible and acceptable for adults with recurrent depression, with no dropouts and high attendance rates (average 7.52 out of 8 sessions) during the intervention.
Preliminary results indicated that while the second group showed a reduction in depressive symptoms and an increase in self-compassion, the first group did not experience significant changes, highlighting the need for further research in a larger, randomized controlled trial.
The Co-creation and Feasibility of a Compassion Training as a Follow-up to Mindfulness-Based Cognitive Therapy in Patients with Recurrent Depression.Schuling, R., Huijbers, M., Jansen, H., et al.[2020]
The online compassion-focused intervention, mindfulness-based compassionate living (MBCL), significantly reduced depressive and anxiety symptoms and increased self-compassion in 122 participants over 8 weeks, with medium to large effect sizes.
These positive effects were maintained for 6 months after the intervention, indicating that MBCL can be an effective long-term strategy for individuals with high self-criticism.
An Internet-Based Compassion-Focused Intervention for Increased Self-Criticism: A Randomized Controlled Trial.Krieger, T., Reber, F., von Glutz, B., et al.[2019]
In a pilot study of 11 patients with chronic depression, a 12-week program combining mindfulness and compassion exercises significantly reduced depression severity, with improvements continuing at a 3-month follow-up.
The treatment led to better emotion regulation, including increased acceptance of emotions and decreased rumination, suggesting that mindfulness and compassion practices could enhance therapeutic options for chronic depression.
Effects of a 12-Week Mindfulness, Compassion, and Loving Kindness Program on Chronic Depression: A Pilot Within-Subjects Wait-List Controlled Trial.Graser, J., Höfling, V., Weβlau, C., et al.[2020]

References

The Co-creation and Feasibility of a Compassion Training as a Follow-up to Mindfulness-Based Cognitive Therapy in Patients with Recurrent Depression. [2020]
An Internet-Based Compassion-Focused Intervention for Increased Self-Criticism: A Randomized Controlled Trial. [2019]
Effects of a 12-Week Mindfulness, Compassion, and Loving Kindness Program on Chronic Depression: A Pilot Within-Subjects Wait-List Controlled Trial. [2020]
Self-compassion in clinical practice. [2013]
Effects of Mindfulness Based Cognitive Therapy (MBCT) and Compassion Focused Therapy (CFT) on Symptom Change, Mindfulness, Self-Compassion, and Rumination in Clients With Depression, Anxiety, and Stress. [2020]
A wait-list randomized controlled trial of loving-kindness meditation programme for self-criticism. [2022]
Randomised Controlled Trial of an Online Version of Compassion Mind Training in a Nonclinical Sample. [2021]
Dispositional Mindfulness and Self-Compassion Buffer the Effects of COVID-19 Stress on Depression and Anxiety Symptoms. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security